Last Updated: September 28, 2026

Ajanta Pharma Ltd Company Profile

✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for AJANTA PHARMA LTD

AJANTA PHARMA LTD has seventy-two approved drugs.

There are six tentative approvals on AJANTA PHARMA LTD drugs.

Summary for Ajanta Pharma Ltd

US Patents:	0
Tradenames:	59
Ingredients:	58
NDAs:	72

Drugs and US Patents for Ajanta Pharma Ltd

+ Get email alerts for changes to this table

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Ajanta Pharma Ltd	SILDENAFIL CITRATE	sildenafil citrate	TABLET;ORAL	206401-003	Oct 12, 2018	AB	RX	No	No		⤷ Start Trial				⤷ Start Trial
Ajanta Pharma Ltd	OLANZAPINE	olanzapine	TABLET, ORALLY DISINTEGRATING;ORAL	204320-003	May 30, 2017		DISCN	No	No		⤷ Start Trial				⤷ Start Trial
Ajanta Pharma Ltd	GUANFACINE HYDROCHLORIDE	guanfacine hydrochloride	TABLET;ORAL	217293-001	Apr 27, 2023	AB	RX	No	No		⤷ Start Trial				⤷ Start Trial
Ajanta Pharma Ltd	DOXEPIN HYDROCHLORIDE	doxepin hydrochloride	CAPSULE;ORAL	212624-005	Sep 13, 2019	AB	RX	No	No		⤷ Start Trial				⤷ Start Trial
Ajanta Pharma Ltd	DAPAGLIFLOZIN	dapagliflozin	TABLET;ORAL	211482-002	Apr 6, 2026	AB	RX	No	No		⤷ Start Trial				⤷ Start Trial
Ajanta Pharma Ltd	FENOFIBRATE (MICRONIZED)	fenofibrate	CAPSULE;ORAL	210705-003	Sep 10, 2018	AB	RX	No	Yes		⤷ Start Trial				⤷ Start Trial
Ajanta Pharma Ltd	PALIPERIDONE	paliperidone	TABLET, EXTENDED RELEASE;ORAL	218514-001	Jun 26, 2024	AB	RX	No	No		⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Ajanta Pharma Ltd

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.